3 articles
The German neurotech company becomes the first to receive FDA Breakthrough Device Designation for a brain-computer interface targeting motor recovery after stroke, with its closed-loop Brain Interchange system showing meaningful recovery in a Harborview Medical Center trial.
The startup, led by iota Biosciences founder Michel Maharbiz, is developing a minimally invasive brain-computer interface that pairs neural decoding with a motorized grip-assist glove to restore movement after stroke.
The Pennsylvania company's 60-channel Smart Neurostimulation System is the first device to receive Breakthrough Device Designation for TBI-related memory loss.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.